ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 168 filers reported holding ACCELERON PHARMA INC in Q2 2019. The put-call ratio across all filers is 1.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $6,441,000 | +34.7% | 37,407 | -2.0% | 0.01% | +27.3% |
Q2 2021 | $4,783,000 | -1.6% | 38,163 | +6.4% | 0.01% | -8.3% |
Q1 2021 | $4,863,000 | -23.6% | 35,859 | -28.0% | 0.01% | -25.0% |
Q4 2020 | $6,369,000 | +9.5% | 49,780 | -3.7% | 0.02% | -5.9% |
Q3 2020 | $5,819,000 | +18.5% | 51,712 | +0.3% | 0.02% | +13.3% |
Q2 2020 | $4,911,000 | +13.6% | 51,546 | +7.1% | 0.02% | -6.2% |
Q1 2020 | $4,324,000 | +64.0% | 48,120 | -1.1% | 0.02% | +100.0% |
Q4 2019 | $2,637,000 | +156.8% | 48,669 | +87.2% | 0.01% | +166.7% |
Q3 2019 | $1,027,000 | -13.8% | 26,000 | -10.3% | 0.00% | -25.0% |
Q2 2019 | $1,191,000 | -13.6% | 29,000 | -2.0% | 0.00% | -20.0% |
Q1 2019 | $1,378,000 | -36.2% | 29,600 | -28.1% | 0.01% | -37.5% |
Q4 2018 | $2,160,000 | +40.4% | 41,165 | +53.0% | 0.01% | +33.3% |
Q3 2018 | $1,539,000 | +10160.0% | 26,900 | +8866.7% | 0.01% | – |
Q2 2018 | $15,000 | +25.0% | 300 | 0.0% | 0.00% | – |
Q1 2018 | $12,000 | -14.3% | 300 | -9.1% | 0.00% | – |
Q4 2017 | $14,000 | +16.7% | 330 | 0.0% | 0.00% | – |
Q3 2017 | $12,000 | +33.3% | 330 | +10.0% | 0.00% | – |
Q2 2017 | $9,000 | +12.5% | 300 | 0.0% | 0.00% | – |
Q1 2017 | $8,000 | 0.0% | 300 | 0.0% | 0.00% | – |
Q4 2016 | $8,000 | -27.3% | 300 | 0.0% | 0.00% | – |
Q3 2016 | $11,000 | +10.0% | 300 | 0.0% | 0.00% | – |
Q2 2016 | $10,000 | – | 300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Artal Group S.A. | 1,400,000 | $133,378,000 | 3.73% |
Foresite Capital Management III, LLC | 42,030 | $4,004,000 | 3.56% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 257,249 | $24,508,000 | 2.23% |
Cormorant Asset Management, LP | 600,000 | $57,162,000 | 2.18% |
Avoro Capital Advisors LLC | 1,040,000 | $99,081,000 | 1.96% |
QVT Financial LP | 101,396 | $9,660,000 | 1.64% |
FARALLON CAPITAL MANAGEMENT LLC | 2,100,000 | $200,067,000 | 1.60% |
Rhenman & Partners Asset Management AB | 155,000 | $14,767,000 | 1.60% |
Parkman Healthcare Partners LLC | 57,500 | $5,478,000 | 1.54% |
Ikarian Capital, LLC | 187,700 | $17,882,000 | 1.42% |